AU-011 (Aura Biosciences) is a first-in-class drug being investigated as a treatment for choroidal melanoma with promising early results being reported from an ongoing phase Ib/II clinical trial, according to Amy Schefler, MD.
Editor’s Note: Welcome to “Let's Chat,” a blog series featuring contributions from members of the ophthalmic community.
This article was reviewed by Jill Hopkins, MD
The glaucoma medication market is thriving today with newer medications that are increasingly efficacious with a new mechanism of action.
Optical coherence tomography detects abnormalities and progressive thinning of the retinal nerve fiber layer better than measurement of the visual fields.
This article was reviewed by David R. Chow, MD, FRCSC.
This article was reviewed by Claude F. Burgoyne, MD
This article was reviewed by Jullia A. Rosdahl, MD, PhD
The intraocular pressure-lowering drugs netarsudil ophthalmic solution 0.02% and latanoprost 0.005% administered separately and then compared with the fixed-combination formulation are similar regarding their effect on the corneal endothelium.